Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma
Abstract Deeper insights into omics in the clinical and tumor microenvironments of lung adenocarcinoma (LUAD) could reveal therapy-sensitive subtypes and novel treatments. From a cohort of 1008 samples from Chinese patients with LUAD with whole-genome and transcriptome sequencing data along with com...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2026-01-01
|
| Saila: | Cell Discovery |
| Sarrera elektronikoa: | https://doi.org/10.1038/s41421-025-00863-4 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|